AI Deals Go Round and Round & Cava’s CEO 8/12/26

12 Aug 2026 · 28 min · 11 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

The episode of CNBC’s Squawk Pod (Aug 12, 2026) covers three business/health themes: NVIDIA’s $500B AI infrastructure financing deal, Kava’s earnings amid food-safety fears, and President Trump’s executive order affecting childhood vaccine schedules and state school-entry requirements.

Guests

Ed Zitron (CEO of Easy Primary Research; Better Offline podcast host) critiques NVIDIA’s “vendor financing by proxy,” arguing the demand is concentrated in OpenAI/Anthropic and that hyperscalers’ AI spending is unsustainable. Brett Shulman (CEO/co-founder of fast-casual Mediterranean chain Cava) says Kava’s ingredients weren’t from outbreak areas, but leafy-greens concerns hurt near-term sales; he cites food-safety council and traceability software plus underpricing inflation. Dr. Scott Gottlieb (former FDA Commissioner; Pfizer/Illumina/UnitedHealth board member) argues the EO mainly pressures states to weaken school vaccine mandates, potentially widening red/blue divides; he says there’s no scientific basis for reducing MMR vaccines and links outbreaks to low-coverage religious communities and Mexico-linked produce oversight concerns.

Notable examples

CoreWeave/Lambda GPU contracts; Bloomberg claim that 70% of Microsoft AI revenue is OpenAI; Kava menu “green bowls and pitas”; Gottlieb’s mention of Amish and Slavic communities in outbreaks; Mexico sewage contamination concerns.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Overview of Current Events

0:28 to 0:51

Discussing recent news, including consumer confidence and health outbreaks.

“With Progressive, small business owners save 10 % or more on their commercial auto insurance when they pay in full.”

Overview of Current Events

1:24 to 2:12

Discussing recent news, including consumer confidence and health outbreaks.

“Then the salmonella and cyclospora outbreaks hitting restaurants.”

NVIDIA's Trillion Dollar AI Financing Deal

2:12 to 3:08

Exploration of NVIDIA's significant AI funding deal with Wall Street firms.

“First up today on the podcast, the business news story of the week.”

Critique of NVIDIA's Financing Model

3:08 to 5:22

Interview with Ed Zitron discussing NVIDIA's financing practices and concerns.

“We'll get into this with our anchors the rest of this week, Leslie Picker, Mike Santoli and Brian Sullivan.”

Demand and Profitability Challenges in AI

5:22 to 9:07

Discussion on the demand for AI and the profitability challenges faced by companies.

“And they found a way around actually doing the financing themselves while basically getting all the benefits.”

Kava's Response to Food Safety Issues

9:07 to 14:02

Kava CEO Brett Shulman discusses the company's proactive measures in food safety.

“They don't have consistent return on investment, and they don't have consistent costs, which makes them a nightmare to scale for businesses.”

Cava's Quarter Overview and Market Position

14:02 to 20:21

Discussion on Cava's quarterly performance, market trends, and consumer behavior.

“Obviously, it featured the Cyclospora news and maybe customer reaction to that.”

Vaccine Schedule and Public Health Implications

20:21 to 28:01

Insights on the potential changes to the vaccine schedule and their implications for public health.

“Scott Gottlieb on the potential revision to the recommended vaccine schedule for children and, yeah, the safety of our food supply.”

Evaluating Vaccine Recommendations and Market Pressure

28:01 to 28:54

Understand the pressures on insurers regarding vaccine coverage and recommendations.

“Yeah, I think they're making a lot of calculations.”

Food Safety and Regulatory Practices

28:54 to 30:12

Explore the current state of food safety and the FDA's role in outbreak management.

“I want to ask you about what's going on with our food source and our food supply, because you've got the cyclospora and all of the confirmed cases for that.”
Show all 11 chapters

Challenges in Produce Sourcing

30:12 to 30:59

Learn about the challenges in sourcing produce and the implications for safety.

“Are there other places we can source from them that make it easier to inspect?”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Trading at Schwab is now powered by Ameritrade, bringing you an expanding library of education with even more ways to sharpen your trading skills. Access new online courses, insightful webcasts, articles, engaging videos, and more. All curated just for traders. Plus, guided learning paths with content designed to fit your unique interests. And no sifting to find exactly what you need, so you can spend your time learning to trade brilliantly. Learn more at schwab.com slash trading. As a small business owner, sometimes it feels like no matter how much planning you do, there's always surprises. Like an urgent, expensive repair.

0:35But here's a surprise you'll like. With Progressive, small business owners save 10 % or more on their commercial auto insurance when they pay in full. So enjoy a surprise for once. Get a quote in as little as 8 minutes at ProgressiveCommercial.com. Progressive Casualty Insurance Company and Affiliates. Discounts not available in all states or situations.

1:22Bring in show music, please. them. They help raise the debt. They find the sites. It's vendor financing. Then the salmonella and cyclospora outbreaks hitting restaurants. CAVA CEO Brett Shulman has his eye on consumer confidence.

1:35Dr. Scott Gottlieb:Our ingredients weren't sourced from any of the impacted areas of the food safety outbreaks. We did see broader consumer concerns around leafy green consumption, fresh produce consumption. And in other health news, President Trump has signed an executive order to change childhood vaccines. Former FDA Commissioner Scott Gottlieb on what's to come. You're going to see an effort to go state by state by some of the anti-vaccine groups to put pressure on state legislators to do away with those school entrance requirements. All that today with special guests in our anchor chairs. It is Wednesday, August 12, 2026.

2:11Squawk Pod begins right now.

2:19First up today on the podcast, the business news story of the week. Chipmaker NVIDIA struck a deal with six of the largest Wall Street firms for$500 billion. That's half a trillion dollars to fund the massive build out of artificial intelligence to meet seemingly endless demand. CEO Jensen Huang calls it a big concept and he got buyers. Huang was on CNBC earlier this week. We're talking about an extraordinarily significant infrastructure build. With a very hefty price tag. It's a hefty price tag. Each gigawatt is something like$50-60 billion. And so there's energy involved, there's land power and shell involved, and of course there's the computing part of it.

2:57Jensen Wong believes AI, the power of computing, is the newest asset class, as valuable as stocks, commodities, other investment vehicles.

3:08We'll get into this with our anchors the rest of this week, Leslie Picker, Mike Santoli and Brian Sullivan.

3:14Dr. Scott Gottlieb:Good morning, by the way. Leslie, Michael, good morning. And if this deal, historic in nature, is all good news, the details matter. What types of borrowers will emerge? What will rates look like? Where are these factories going to be built? NVIDIA and the partnering companies say it's time to move forward into the future. The AI market is huge and getting larger. So we talked to a critic of the whole deal. We'll get started with Leslie Picker here, sitting in on Squawk Box. Our next guest says the new initiative is vendor financing by proxy. Ed Zitron is the CEO of Easy Primary Research and host of the Better Offline podcast.

3:51Ed, good to see you. Good to be here. So you don't think this alleviates the concerns about circular financing? No, this fund, which is, by the way, still a memorandum of understanding. We do not actually have contracts. It's just vendor financing. NVIDIA is raising the funding. They're finding the customers. They're the vendor. They're the customer, in some cases, with CoreWeave. They're a large customer with Lambda. They basically pay people to rent back the GPUs that they sell them. They help raise the debt. They find the sites. It's vendor financing. But they've been smarter than the Cisco's and the Lucent's in the past by not actually becoming a bank.

4:26Well, and that's, I think that's an important part in that the financiers that they're working with are the ones who are going to determine what the interest rate is that they lend on, as opposed to NVIDIA removing itself from that process, which creates more of a, you know, traditional kind of lender-borrower dynamic in such that, you know, we will lend to you, but here's the price by which it will cost for you to actually borrow this money. But the trick that NVIDIA does is they lend their credit to companies by not actually lending their credit. With Lambda and CoreWeave, I think they pay them$1.3 billion or more in these four-year-long contracts.

5:02These contracts are then taken to financiers and they say, hey, look, we have a customer. Even though that customer is also the vendor, NVIDIA also propped up CoreWeave's IPO. They invested over$2 billion in them and I think in IRON as well, post-IPO. They are propping up these companies. They are helping them get funding. And they're backstopping deals as a means of, well, funneling money to themselves. And they found a way around actually doing the financing themselves while basically getting all the benefits. Whatever the machinations of how they're getting the capital, lending it, deploying it, what you hear is from somebody in Corweave's position, from any of the hyperscalers, from anybody along the food chain is we are responding to demand signals that cannot be denied.

5:43There is more demand than supply. There is a scarcity trade we need to build in order to find out, you know, where the clearing level is for supply and demand. So I guess NVIDIA's point is you just have to get it out there. And, you know, the demand will take care of those issues. But the thing is, the demand is mostly open AI and anthropic. So Bloomberg actually reported a few days ago that 70 % of Microsoft's AI revenue in fiscal year 26 was OpenAI, which also suggests that Microsoft 365 Copilot and Compute is a single-digit billion business. All of the demand from CoreWeave is OpenAI, Anthropic, Microsoft for OpenAI, and of course, Google for OpenAI, and then OpenAI for itself.

6:24These companies are basically just compute fronts for two unsustainable, unprofitable AI labs that are basically the only growth engine for hyperscalers at this point. Everybody's propping up what is really the end of the era of hyper growth. How can you say they're unsustainable? Well, I mean, they burn tens of billions of dollars a year and have no proof that they will ever find profitability. There is this mythology that inference is profitable. There is no actual proof of this. This is something Dario Amadei said once as a stylized fact in an interview with Dwakesh Patel. No, nobody has actually proven this.

7:00Dr. Scott Gottlieb:Google Gemini. So Sundar Pichai of Google, yes, or Alphabet yesterday said one billion users. I don't know how many of those are layered on top of Gmail. Gmail automatically sort of integrates Gemini. It'll summarize your emails. Copilot, it's sort of automatically, unless you opt out, integrated into Outlook. Do we have any idea, Ed, how much organic use there is of AI, meaning people who just choose to use AI and pay for it, independent of other products like an Outlook, Gmail, etc.? Do we have any idea what that demand case is? Well, yes, we do. So the thing I mentioned with Bloomberg, 70 percent of Microsoft's fiscal year 2026 revenue for AI was from open AI.

7:40So about thirty four billion dollars total. That's co-pilot. So just to be clear, though, ten point three billion dollars of that was everything that wasn't open AI, which means that Microsoft 365 co-pilot is making single digit billions of dollars of revenue. That's pathetic. $261 billion of CapEx Microsoft has spent since the beginning of 2022 for a teeny tiny business. And I know billions sound like a lot of money, but not when you're building data centers. It does it in this case. You're right.

8:08Dr. Scott Gottlieb:And by the way, when we talk about energy demand, I'm actually starting to see the word quadrillion. I'm not joking. Thrown around quintillion, quadrillion, over trillion. So I would imagine you've got two options. Grow the user base massively or raise prices. massively, or some combination of the two to make back up that money. What's the answer? So the problem is, is Sam Altman himself said when they moved all of their enterprise customers and OpenAI and Anthropic over to per million token basis, paying for the actual cost of AI. And within one month or two, I think Uber blew through their entire annual token budget in a single quarter.

8:46You had everybody screaming like they were being pecked to death by birds about. And Sam Altman said, yeah, this is a huge problem. This is the man who's meant to be the head of the biggest startup of all time. And his answer was, yeah, people don't like that. And the thing is, people really don't. And we have this misalignment with the price of AI, the cost of running AI, and, well, actual consumer demand. And the problem is that large language models are not consistent products. They don't have consistent return on investment, and they don't have consistent costs, which makes them a nightmare to scale for businesses.

9:16And so there's really no opportunity to raise prices at this point, because we've already seen what happens. Customers protest. How does the debate over open source versus closed factor into that business model, and especially the moats that seem to be a little bit dubious at this point? Well, here's the funny thing. Dario Amadei position of Anthropic, he positions open source as anti-American, that we let the Chinese models take over. Well, that's anti-American. I can think of nothing more American than having competition in the large language model arena. They're terrified because people have found a cheaper, though not confirmed as profitable, way of doing much the same thing of beating them on benchmarks or matching them on benchmarks.

9:57So they're scared of China because they know that China is operating with less GPUs, though they do have access to Blackwell, and operating with less money, and yet doing about the same thing. And they'll say it's distillation. They'll say all of these things. But what they're actually afraid of isn't China, it's competition. If the IPOs of OpenAI and Anthropic get done as expected, let's say whether it's the next year or so, that would seem to capitalize them to a point where they can run this experiment for quite a long time. So what are the, I don't know, I guess investment implications of all this?

10:29So, an analyst that UBS found about a month ago, they estimate that 48 % of Google Cloud's entire revenue next year will come from Anthropic and OpenAI. That is over$124 billion, and that's on top of tens of billions of dollars with CoreWeave, Aira, Microsoft, and all sorts of others. Point I'm making is, if they go public, and it is an if at this point, especially for OpenAI, they will have to raise$100 billion,$200 billion each every year in perpetuity. The Wall Street Journal's and Nisa Gardizi reported the other day that OpenAI plans to spend$750 billion on compute by the end of 2030. That's less than three and a half years away.

11:10I just don't see how it's possible. That's more than the hyperscalers are racing to build the data centers. Yeah, the numbers are so eye-popping. Ed, thank you. Thank you. Appreciate your time this morning. Cheese will be next. Coming up on SquawkPod, fast casual chain Kava may not have been directly affected by recent salmonella or cyclospora outbreaks. That's a relief. But CEO Brett Shulman is prepared just in case.

11:36Dr. Scott Gottlieb:We've been proactive and taken measures over the years to invest ahead of our growth in food safety, doing things like standing up an external food safety council or investing in food traceability software so that if there were an issue to arise, that we could identify it and address it very quickly. Keeping your sad desk lunch safe right after this. trading at schwab is now powered by ameritrade bringing you an expanding library of education with even more ways to sharpen your trading skills access new online courses insightful webcasts articles engaging videos and more all curated just for traders plus guided learning paths with content designed to fit your unique interests and no sifting to find exactly what you need so you can spend your time learning to trade brilliantly learn more at schwab.com Looking for a little extra fun?

12:28Chumba Casino lets you play for free with daily login rewards and a cheeky little welcome bonus when you sign up. Explore hundreds of online social casino games and jump in whenever it works for you. No routines, no pressure, just entertainment on your terms. That's Chumba. No purchase necessary. VGW group void where prohibited by logs. See terms and conditions for details. 21 plus. What made you confident that you could do something that hadn't been done before? I have no fear of failure. Trailblazing women changing the game. One of my favorite pieces of advice, think about what your boss's boss needs.

13:09Leadership can look in many, many different forms. It really does come down to just trusting yourself. Life is short and you just got to think big to accomplish big things. Julia Boorstin hosts CNBC Changemakers and Power players. New episodes every Tuesday, wherever you get your podcasts.

13:28Welcome back to Squawk Pod. It's time for lunch. Fast casual restaurant Kava reported a boost in profit from this time last year. In the second quarter, the Mediterranean chain found an uptick in traffic, despite a broader dip related to the outbreaks of foodborne illness that shook consumer confidence in produce. CEO and co-founder of Kava, Brett Shulman, sat down with our Leslie Picker, Mike Santoli, and Brian Sullivan this morning. Here's Mike. It's good to see you, Brett. Yeah, thanks for having me. Coming in. So obviously, pretty good comps, traffic. Talk about the way the quarter unfolded.

14:04Obviously, it featured the Cyclospora news and maybe customer reaction to that.

14:09Dr. Scott Gottlieb:Yeah, so we had a really strong quarter. I want to give a shout out to our 15 ,000 strong team members who deliver heart, health, and humanity every day. It's just a reflection of the great work they're doing. As we exited the second quarter, while we weren't connected or our ingredients weren't sourced from any of the impacted areas of the food safety outbreaks, we did see broader consumer concerns around leafy green consumption, fresh produce consumption that did impact our near-term sales trends, but we've since seen those trends begin to rebound. There was some, I guess, commentary. You know, you beat in the quarter relative to the latest estimates, but maintain guidance.

14:44Yeah. So what are you seeing or projecting that has people saying maybe it's a little conservative.

14:49Dr. Scott Gottlieb:Well, just given the broader uncertainty around the food safety outbreaks, combined with the fluid macroeconomic and geopolitical situation, as well as potential persistent inflationary pressures on the consumer, we thought it was prudent to maintain our current guidance. So you're not a lettuce, I can't believe I'm going to say these words, lettuce-heavy restaurant. Well, that's the beautiful thing about our - Right, so you're not, I don't think of like shaved lettuce when I think about kava. So how much, in fact, I went there Monday. I didn't know you were on, obviously, whatever. I just went there for lunch.

15:16Dr. Scott Gottlieb:It was delicious. My shirt loved it, too, by the way. Is there a way in which maybe you're helped by that? Because I don't think of you guys necessarily as like a like a shaved lettuce type restaurant. Well, we are definitely produce forward. So there's definitely some concerns around that, I think. But the beauty about our Mediterranean cuisine and our our menu is 17.4 billion combinations, a broad variety of ingredients that you can opt into shift into green bowls and pitas. so you can have a meal that you feel really comfortable in no matter what the situation is. How do you think about supply chain safety?

15:50You know, I was reading about how lettuce is one of the most difficult and least regulated types of produce that, you know, comes across the border and it's difficult to patrol for safety. But as a business owner, how do you assess your supply chain and make sure that it is operating with the highest standards and so you won't be embroiled in all of this?

16:12Dr. Scott Gottlieb:Yeah, food safety is foundational to the relationship with our guests and frankly, for any restaurant and their guests, which is why we've been proactive and taken measures over the years to invest ahead of our growth in food safety, doing things like standing up an external food safety council of industry leading experts like Dr. James Marsden, Dr. David Atchison, or investing in food traceability software so that if there were an issue to arise, that we could identify it and address it very quickly. You mentioned, you know, at least in the air, the consumers maybe being a little bit hesitant at certain income tiers and things like that, not necessarily eager to spend more.

16:51You're kind of absorbing most of the inflation. What are you doing in terms of list price?

16:56Dr. Scott Gottlieb:Yeah, it's been a very intentional strategy for us for a number of years now. We've talked in the past, we've underpriced CPI by over 10 percent in recent years, taken less than half the price increases of the average restaurant company. Even when you look at 2026, we took about 1.5 % menu price adjustment at the beginning of the year with no current plans to take additional price when CPI is running about 3.1%. So less than half, really trying to work on behalf of our guests, invest in our guests, invest in our teams, which is driving that sustainable traffic growth. People grouse about price, but I don't know if they actually do anything about it.

17:28I mean, the lines at your places are, I don't say long, but they're good.

17:34Dr. Scott Gottlieb:I mean, there's customers that are in there. Who are you taking market share from? It's not going to be a net ad, right? There's only seven days in the week. Who then are you taking the customer from? I think we're seeing people trade into Cava from all different places, whether that's limited service, full service grocery. I think our difficult is our food is difficult to recreate at home. It's very unique. And I think what's really encouraging is that we see across all income strata. We see strength in our markets and we see strength even in our lower median household incomes, where we're seeing those guests actually opt into higher premium attachments.

18:12Dr. Scott Gottlieb:So they feel like they can trade up into our new pomegranate glazed salmon or our harissa honey chicken and still feel like they're getting a great value and it fits within their budget. Yeah, that was surprising to me. I saw that in your report that it was the lower income consumers that were actually doing more of the adding on. Is that unique to this environment or is that something that you've seen historically as well? I ask because there's all this debate over the K-shaped economy and what consumers are doing. We've seen that grow over the years, as I talked about how we've tried to improve our relative value proposition each and every year under pricing inflation, making our food more accessible to communities across the country and welcoming more people to the Kava table.

18:51Kava was sort of, you know, instrumental in getting out in front of the Mediterranean cuisine trend, making it more accessible. Are you looking over your shoulder for the next thing in terms of like whether there's a certain fashion element and, you know, customers like to try new things? Is there anything you're looking to incorporate or that you see as on the come?

19:11Dr. Scott Gottlieb:We're always trying to evolve our menu within our Mediterranean lens, within our identity. So a lot of times I think restaurants can start to evolve outside their identity. We want to evolve within our identity and stay true to our Mediterranean essence. Is there an international opportunity for you guys? I think down the road we're focused on domestic growth. We think we have significant white space opportunity across the country. What is white space opportunity? Right. I'm not my lingo. You're a former banker, FBR, right? Friedman, Billings, Ramsey. And Alex Brown back in the day. And back in the day.

Read the full transcript

19:43Dr. Scott Gottlieb:So you're a D.C. guy, is my guest. I think you're a Terp. You're a Terp. You're a Terp. Talk about that. But is there, you know, one day we go to London and we're going to see a Cava. Yeah. Maybe one day in the future. We're focused on domestic growth. We announced on our call we're going to expand to Las Vegas later this year. And the next year, we're finally going to make it to Northern California in the Bay Area. So there's a lot of the country that we do not have a cov in, whether it's growth in existing markets or growth in markets we don't currently operate in today. Yeah, not not so much density of white space, as you might say.

20:17Brett, thank you. Don't go anywhere. Still to come on Squawk Pod, Dr. Scott Gottlieb on the potential revision to the recommended vaccine schedule for children and, yeah, the safety of our food supply.

20:30Dr. Scott Gottlieb:Something happened in that growing region, central Mexico. though, where sewage somehow got onto the growing fields, perhaps through irrigation. Some of those fields we can't inspect. We can't send U.S. FDA inspectors into those regions because it's unsafe. Cartels operate in those regions. Trading at Schwab is now powered by Ameritrade, bringing you an expanding library of education with even more ways to sharpen your trading skills. Access new online courses, insightful webcasts, articles, engaging videos, and more. All curated just for traders. Plus, guided learning paths with content designed to fit your unique interests.

21:06And no sifting to find exactly what you need, so you can spend your time learning to trade brilliantly. Learn more at schwab.com slash trading.

21:14Dr. Scott Gottlieb:Tyler Reddick here from 2311 Racing. And Bubba Wallace. You know what's the worst part of a race? A rain delay. Sitting around waiting for the track to dry is dull. But instead of waiting, we hang out with Chumpa Casino. Social casino slots, bingo, solitaire, plenty of fun to keep us entertained. So why let a rain delay slow you down? Play now at ChumbaCasino.com. Let's Chumba! No purchase necessary. VGW Group. Void where prohibited by law. CT &Cs 21 Plus. Sponsored by Chumba Casino. What made you confident that you could do something that hadn't been done before? I have no fear of failure. Trailblazing women changing the game.

21:53One of my favorite pieces of advice, think about what your boss's boss needs. Leadership can look in many, many different forms. It really does come down to just trusting yourself. Life is short and you just got to think big to accomplish big things. Julia Boorstin hosts CNBC Changemakers and Power Players. New episodes every Tuesday, wherever you get your podcasts.

22:17You're listening to Squawk Pod from CNBC, where we are digging into a few headlines that could change our health in America. Today's anchors are Leslie Picker, Mike Santoli and Brian Sullivan. Leslie takes things from here. President Trump signing an executive order on Monday that could have been the vaccination schedule for children in the U.S. Joining us now, former FDA Commissioner Dr. Scott Gottlieb. He is a Pfizer, Illumina and UnitedHealth Group board member and a CNBC contributor. Dr. Gottlieb, good to see you. Thanks. What do you think this means for a nation that has already become more and increasingly skeptical of vaccinations broadly?

22:56Dr. Scott Gottlieb:Yeah, look, I think the discussion around this is going to feed some of those skepticisms. And so it's going to exacerbate that. I think in terms of just the near-term impact, it's likely to be very limited. I don't think the manufacturers are going to reformulate the vaccines. I think that the insurers are going to continue to provide coverage for it. People will start to make the decisions, providers and insurance companies, based on recommendations from groups like the American Pediatric Association. So I don't think there's going to be an immediate impact on availability of the MMR vaccine.

23:22Dr. Scott Gottlieb:I think in the near term, though, if you look at the EO, in my view, the most significant part of this executive order is what it does to try to put pressure on states to do away with school entrance requirements and state based mandates. And so I think in the in the intermediate term, you're going to see an effort to go state by state by some of the anti-vaccine groups to put pressure on state legislators to do away with those school entrance requirements. And if you look at the EO, it specifically talks about using the Department of Education, the Department of Health and Human Services to try to sanction certain states that don't provide broad exemptions.

23:55Dr. Scott Gottlieb:It also talks about DOJ intervening in litigation, state based litigation for states that don't broaden their exemptions. So I think we're going to see an increasing divide in this country between, unfortunately, red and blue states, where some of the red states start to weaken those school entrance requirements and those mandates. Blue states maintain them. We've already seen that play out. If you look at the data, vaccination rates have fallen based on political divides. I think that's going to be exacerbated over time. Is there anything in the scientific data that supports these changes? Has anything changed in the scientific community that would suggest it is beneficial to divide the MMR vaccine or to kind of pare back the number of vaccines that children get?

24:38Dr. Scott Gottlieb:Yeah, look, I certainly don't think so. The issues around the MMR vaccine and a purported link to autism has been one of the most exhaustively studied questions in scientific history. I mean, this goes back 20, 25 years. I was at FDA in the early 2000s, and we launched some very large studies to look specifically at this question. So I think this has been exhaustively studied, and sometimes we have to take no for an answer. In terms of why those vaccines are put into a single shot is because we want to try to reduce the burden on providers and patients. Those vaccines are all live attenuated vaccines.

25:09Dr. Scott Gottlieb:So they're similar in formulation so they can be co-formulated together. So the goal was to try to reduce the number of shots children get to reduce the inconvenience to parents and providers and also make sure children are getting vaccinated. So there was a logic in combining them. Fair enough. I want to I want to push back a little bit, doctor, and say this, that that there's a lot of lazy reporting out there about measles outbreaks where it's like, well, we hear that outbreaks are in Texas and in South Carolina. and it automatically defaults to some political thing. Yeah, I agree with that.

25:37Dr. Scott Gottlieb:That's lazy reporting. If you look at the data, the data is publicly available. Well, what I will say to that - No, no, let me finish. This is critical. This is not, it may be political, but it's also very religious. A lot of the outbreaks, the majority of the outbreaks in Texas were among basically an Amish community. They're not going to take vaccines no matter what you do. One of the South Carolina outbreaks, almost all of it was centered around a tight-knit Slavic - That's where I was going to go. Very religious community in Spartanburg, South Carolina. These are not people who are anti-vaxxers because of politics.

26:07Dr. Scott Gottlieb:They just, their religion does not believe in it. So what are we willing, and there's a lot of just laziness out there reporting where it's like, well, they're Trumpers, so they're anti-vaccine. I'm sure there's some of that. But how much are we willing to tell a religious community that doesn't believe in this and hasn't for 100 years and won't 100 years from now that they're required to do something that their religion says they should not do? And that's the challenge. Yeah, look, there are religious exemptions on the books. I think to your point, that's where I was going to go in responding to your comment.

26:37Dr. Scott Gottlieb:I'm sorry I interrupted. But there are pockets in this country where vaccination rates are extremely low. Oftentimes those are in communities where you have people with a religious belief that, you know, obviates getting vaccinated. And that's what we've seen with some of these outbreaks. If you do look state by state and you were to break this down based on, you know, sort of the politics of the state, you do see lower vaccination rates in certain certain red states in the south, for example. So we are starting to see a political divide in this. I don't think that should be surprising at all.

27:07Dr. Scott Gottlieb:It's not that severe right now. So if you look at, for example, the data that came out, districts that Trump won, the vaccination rate for MMR is about 90 percent. Districts at Harris 1, it's about 93.5%. So not a huge divide, but a divide. But are we willing to tell religious communities you have to do this? That's the challenge I think that we face. It's not the challenge because most states have religious exemptions. And they're not going to reverse those. Well, I think the exemptions are going to be widened. This is sort of moving in one direction. So I don't think any state's going to tighten the exemptions.

27:41Dr. Scott Gottlieb:You've seen California, some other states do that over time. when MMR rates went down, you started to see measles outbreaks. I don't think that's going to happen. I think what's going to happen is it's going to move in the other direction. What is the broader public health implications of this? You mentioned you think insurers are still going to cover the childhood vaccinations. That would imply to me that insurers making this kind of cold calculation of cost benefit believe that it's better long-term cost-wise and outcomes to actually cover these things. Yeah, I think they're making a lot of calculations.

28:12Dr. Scott Gottlieb:I think it is a calculation based on the health of the population. I think it's also providers putting pressure on insurers to continue to cover this. They'll continue to cover the existing schedule because that's what the American Pediatric Association is recommending. I think the difficulty is going to be if companies introduce new pediatric vaccines, you're dependent upon the ACIP to recommend that, to move it into the schedule. And so will the American Pediatric Association set up an analogous process to start to recommend new vaccines? And so it's going to put some pressure on the market when it comes to new vaccine development and getting those recommended.

28:44Dr. Scott Gottlieb:Right now, what's going to happen is I think the existing recommendations as they existed prior to a year or two ago are going to get frozen in place. And that's what we'll be following. I want to ask you about what's going on with our food source and our food supply, because you've got the cyclospora and all of the confirmed cases for that. You've got salmonella. How should we be thinking about just our food consumption habits, as well as just from a broader societal regulatory standpoint, what's going into our food supply chain? Yeah, look, I don't think we should change our habits. I don't think the food supply is less safe today than it was two or three years ago.

29:22Dr. Scott Gottlieb:I think FDA has done a good job isolating the source of these outbreaks once they've been identified. I think the slowness was in identifying these clusters of infection. But once we did, FDA came in and isolated the food source very quickly. that owed in part to the fact that there were good intermediaries in the supply chain like Chipotle, like Taco Bell, like Taylor Farms, are able to isolate within their own supply chains. I think it does call into question produce coming from Mexico. So there is a lot of these pathogens do seem to be emanating from Mexico this season. Something happened in that growing region in central Mexico where sewage somehow got onto the growing fields, perhaps through irrigation.

29:58Dr. Scott Gottlieb:You know, some of those fields we can't inspect. We can't send U.S. FDA inspectors into those regions because it's unsafe. Cartels operate in those regions. I don't have any reason to believe that FDA wasn't inspecting the fields that are implicated in these outbreaks. But it does call into question whether or not we should be increasing our oversight on those growing fields. Are there other places we can source from them that make it easier to inspect? Not really. I mean, we can source. We do source some of this produce from California, some of it also from Arizona. if you're thinking about leafy green vegetables.

30:31Dr. Scott Gottlieb:Avocados come from California as well, but 80 % of the supply comes from Mexico. They're cut off right now as well, or were cut off briefly. We're dependent upon Mexico and South America to provide a lot of produce. The harvest shifts around depending on the season, and this is the season when we're harvesting from Mexico. We're not typically harvesting romaine lettuce and other things from California at this point in the year. Yeah, all right. Very helpful, Dr. Gottlieb. Thank you so much. Thanks a lot. And that's Squawk Pod for today. Thanks for listening on this August Wednesday. Squawk Box is hosted by Joe Kernan, Becky Quick, and Andrew Ross Sorkin.

31:11Thanks to our gang of Brian, Mike, and Leslie for sitting in today. On TV, you can tune in weekday mornings on CNBC starting at 6 Eastern. Or get the smartest takes and analysis from our TV show right into your ears when you follow Squawk Pod wherever you get your podcasts. That's it. We'll meet you right back here tomorrow. We are clear. Thanks, guys.

31:39Trading at Schwab is now powered by Ameritrade, bringing you an expanding library of education with even more ways to sharpen your trading skills. Access new online courses, insightful webcasts, articles, engaging videos, and more. All curated just for traders. Plus, guided learning paths with content designed to fit your unique interests. And no sifting to find exactly what you need, so you can spend your time learning to trade brilliantly. Learn more at schwab.com slash trading.

From the publisher

Nvidia’s $500 billion deal with top Wall Street firms has sparked a debate about circular spending in the AI ecosystem. Ed Zitron is a critic of the investments pouring into the industry, and he shares his bearish take on AI. Brett Schulman, CEO of fast casual chain Cava, is keeping his eye on consumer confidence amid salmonella and cyclospora outbreaks in the U.S. Schulman discusses the impact foodborne illness has had on the restaurants, despite Cava’s food supply chain being unimpacted by issues. Plus, former FDA Commissioner Dr. Scott Gottlieb discusses President Trump’s Executive Order on childhood vaccines and the pressure it may create for state leadership. 

 

Ed Zitron - 03:47

Brett Schulman - 14:03

Dr. Scott Gottlieb - 22:41 

 

In this episode:

Leslie Picker, @LesliePicker

Michael Santoli, @michaelsantoli

Brian Sullivan, @SullyCNBC

Katie Kramer, @Kramer_Katie


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More from Squawk Pod

All 546 episodes
AI Deals Go Round and Round & Cava’s CEO 8/12/26Squawk Pod · 28 min
Listen in VO